Gopisankar MG currently works as a PhD student at the Centre for Medicines Use and Safety (CMUS), Monash University, where he focuses on research in Health economic evaluation of prognostic model guided midlife dementia risk reduction. His areas of interests are health economics, clinical prediction models, pharmacogenomics and pharmacokinetics.
